Literature DB >> 2654289

Course of transplanted Heymann nephritis kidney in normal host. Implications for mechanism of proteinuria in membranous glomerulonephropathy.

S P Makker1, J J Kanalas.   

Abstract

Heymann nephritis [model of membranous glomerulonephropathy (MGN)] kidneys (n = 20) with proteinuria were transplanted into unilaterally nephrectomized normal syngeneic Lewis recipient rats to study the course of established MGN lesion in normal milieu. Concurrent with the loss of C3 staining from the MGN lesion at 2 to 4 wk after transplantation, the proteinuria decreased from the transplanted kidney (p less than 0.02). Thereafter, from 2 to 28 wk no further decrease was noted in proteinuria which stabilized at a lower but still abnormal level. No appreciable decrease in IgG deposits in MGN lesion was noted up to 12 wk but at 28 wk the deposits had decreased significantly (p less than 0.005). However, the deposits did not resolve completely even at 40 wk. The results indicate that in MGN one component of proteinuria is due to ongoing activation of C with the deposition of new antibody and the other is perhaps due to structural damage to glomerular filter. The former appears reversible and the later irreversible. Although the resolution of IgG deposits in the lesion is very slow significant improvement can occur with time (several months).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654289

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

Review 2.  Treatment of membranous nephropathy: time for a paradigm shift.

Authors:  Piero Ruggenenti; Fernando C Fervenza; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

3.  Anti-phospholipase A2 receptor antibody in membranous nephropathy.

Authors:  Weisong Qin; Laurence H Beck; Caihong Zeng; Zhaohong Chen; Shijun Li; Ke Zuo; David J Salant; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

4.  c-mip impairs podocyte proximal signaling and induces heavy proteinuria.

Authors:  Shao-Yu Zhang; Maud Kamal; Karine Dahan; André Pawlak; Virginie Ory; Dominique Desvaux; Vincent Audard; Marina Candelier; Fatima BenMohamed; Fatima Ben Mohamed; Marie Matignon; Christo Christov; Xavier Decrouy; Veronique Bernard; Gilles Mangiapan; Philippe Lang; Georges Guellaën; Pierre Ronco; Djillali Sahali
Journal:  Sci Signal       Date:  2010-05-18       Impact factor: 8.192

Review 5.  An evaluation of experimental models of glomerulonephritis.

Authors:  P N Furness; K Harris
Journal:  Int J Exp Pathol       Date:  1994-02       Impact factor: 1.925

Review 6.  Rituximab therapy for membranous nephropathy: a systematic review.

Authors:  Andrew S Bomback; Vimal K Derebail; Julie G McGregor; Abhijit V Kshirsagar; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-11       Impact factor: 8.237

7.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

8.  Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Maria Chiara Sghirlanzoni; Elena Gagliardini; Sara Conti; Flavio Gaspari; Gianfranco Marchetti; Mauro Abbate; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-06       Impact factor: 8.237

9.  Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.

Authors:  C J Pruchno; M M Burns; M Schulze; R J Johnson; P J Baker; C E Alpers; W G Couser
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

Review 10.  Membranous nephropathy: from models to man.

Authors:  Laurence H Beck; David J Salant
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.